JENNEFER WILL: Open Payments
NPI 1821839754 · BARNEVELD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 106 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $456 · 2025 $1,931
Food & beverage: $1,931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $351 |
| AstraZeneca Pharmaceuticals LP | 13 | $256 |
| PFIZER INC. | 10 | $166 |
| Amgen Inc. | 12 | $163 |
| Lilly USA, LLC | 9 | $143 |
| Alkermes, Inc. | 5 | $125 |
| Lundbeck LLC | 6 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Novo Nordisk Inc | 4 | $83 |
| Braeburn Inc. | 4 | $77 |
Products named: VRAYLAR, REXULTI, MOUNJARO, VIVITROL, NURTEC ODT, AIRSUPRA, OTEZLA, FARXIGA.
Industry payments across NY — which companies pay providers there.
